We are live on ! Find out more
NUVB icon

Nuvation Bio

16 hedge funds and large institutions have $40.9M invested in Nuvation Bio in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

25.49% more ownership

Funds ownership: 0%25.49% (+25%)

Holders
16
Holders Change
+16
Holders Change %
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

NUVB Hedge Fund Activity: Q3 2020 in Review

16 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q3 2020, worth a combined $40.9M.

Buyers outnumbered sellers: 16 funds opened new NUVB positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $8.64M.

  • 16 institutional investors held Nuvation Bio (NUVB) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $40.9M of Nuvation Bio stock for Q3 2020.
  • 16 funds opened new Nuvation Bio positions in Q3 2020 and 0 closed out, a net change of +16 holders.
  • The largest Nuvation Bio buyer in Q3 2020 was Adage Capital Partners, an estimated $8.64M added.

Based on aggregated 13F filings for Q3 2020.